Big Pharma Counted on This Loophole. It May Be Closing.
In This Article:
Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other drugmakers.
Terms and Privacy Policy